LeMaitre Vascular, Inc. (LMAT)
USD 90.34
(-0.65%)
USD 90.34
(-0.65%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 48.87 Million USD | 15.62% |
| 2022 | 42.27 Million USD | 9.38% |
| 2021 | 38.65 Million USD | -51.83% |
| 2020 | 80.23 Million USD | 99.62% |
| 2019 | 40.19 Million USD | 75.89% |
| 2018 | 22.85 Million USD | 38.06% |
| 2017 | 16.55 Million USD | 14.76% |
| 2016 | 14.42 Million USD | 12.51% |
| 2015 | 12.82 Million USD | -3.5% |
| 2014 | 13.28 Million USD | -4.63% |
| 2013 | 13.93 Million USD | 36.94% |
| 2012 | 10.17 Million USD | 33.86% |
| 2011 | 7.59 Million USD | -30.4% |
| 2010 | 10.91 Million USD | 25.6% |
| 2009 | 8.69 Million USD | 0.49% |
| 2008 | 8.65 Million USD | -31.15% |
| 2007 | 12.56 Million USD | 100.59% |
| 2006 | 6.26 Million USD | -4.1% |
| 2005 | 6.53 Million USD | 14.84% |
| 2004 | 5.68 Million USD | 0.0% |
| 2002 | 4.69 Million USD | -6.94% |
| 2001 | 5.04 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 45.45 Million USD | -7.01% |
| 2024 Q2 | 43.54 Million USD | -4.2% |
| 2024 Q3 | 45.95 Million USD | 5.52% |
| 2023 Q4 | 48.87 Million USD | 7.72% |
| 2023 FY | 48.87 Million USD | 15.62% |
| 2023 Q1 | 40.7 Million USD | -3.72% |
| 2023 Q2 | 42.64 Million USD | 4.76% |
| 2023 Q3 | 45.37 Million USD | 6.41% |
| 2022 Q2 | 41.39 Million USD | 19.4% |
| 2022 Q3 | 40.8 Million USD | -1.43% |
| 2022 Q4 | 42.27 Million USD | 3.61% |
| 2022 Q1 | 34.66 Million USD | -10.31% |
| 2022 FY | 42.27 Million USD | 9.38% |
| 2021 Q4 | 38.65 Million USD | -4.39% |
| 2021 FY | 38.65 Million USD | -51.83% |
| 2021 Q1 | 69.84 Million USD | -12.95% |
| 2021 Q2 | 60.67 Million USD | -13.13% |
| 2021 Q3 | 40.42 Million USD | -33.37% |
| 2020 Q3 | 100.58 Million USD | -2.43% |
| 2020 Q4 | 80.23 Million USD | -20.23% |
| 2020 Q2 | 103.08 Million USD | 188.58% |
| 2020 Q1 | 35.72 Million USD | -11.13% |
| 2020 FY | 80.23 Million USD | 99.62% |
| 2019 FY | 40.19 Million USD | 75.89% |
| 2019 Q3 | 27.69 Million USD | 10.25% |
| 2019 Q4 | 40.19 Million USD | 45.12% |
| 2019 Q1 | 27.16 Million USD | 18.86% |
| 2019 Q2 | 25.12 Million USD | -7.51% |
| 2018 Q1 | 15.94 Million USD | -3.7% |
| 2018 Q3 | 18.98 Million USD | 16.04% |
| 2018 Q4 | 22.85 Million USD | 20.41% |
| 2018 FY | 22.85 Million USD | 38.06% |
| 2018 Q2 | 16.35 Million USD | 2.61% |
| 2017 Q3 | 15.15 Million USD | 10.28% |
| 2017 Q1 | 14.9 Million USD | 3.33% |
| 2017 FY | 16.55 Million USD | 14.76% |
| 2017 Q4 | 16.55 Million USD | 9.22% |
| 2017 Q2 | 13.74 Million USD | -7.79% |
| 2016 Q4 | 14.42 Million USD | -1.31% |
| 2016 FY | 14.42 Million USD | 12.51% |
| 2016 Q3 | 14.61 Million USD | 15.28% |
| 2016 Q2 | 12.67 Million USD | -0.63% |
| 2016 Q1 | 12.76 Million USD | -0.47% |
| 2015 Q2 | 12.79 Million USD | 9.89% |
| 2015 Q1 | 11.64 Million USD | -12.34% |
| 2015 Q4 | 12.82 Million USD | 3.17% |
| 2015 FY | 12.82 Million USD | -3.5% |
| 2015 Q3 | 12.42 Million USD | -2.91% |
| 2014 Q1 | 12.48 Million USD | -10.39% |
| 2014 FY | 13.28 Million USD | -4.63% |
| 2014 Q2 | 12.75 Million USD | 2.17% |
| 2014 Q3 | 16.28 Million USD | 27.7% |
| 2014 Q4 | 13.28 Million USD | -18.43% |
| 2013 Q4 | 13.93 Million USD | 25.0% |
| 2013 Q1 | 9.9 Million USD | -2.6% |
| 2013 Q2 | 9.54 Million USD | -3.67% |
| 2013 Q3 | 11.14 Million USD | 16.76% |
| 2013 FY | 13.93 Million USD | 36.94% |
| 2012 FY | 10.17 Million USD | 33.86% |
| 2012 Q4 | 10.17 Million USD | 9.54% |
| 2012 Q2 | 8.02 Million USD | 9.3% |
| 2012 Q3 | 9.28 Million USD | 15.7% |
| 2012 Q1 | 7.34 Million USD | -3.37% |
| 2011 Q4 | 7.59 Million USD | -26.78% |
| 2011 Q1 | 8.74 Million USD | -19.93% |
| 2011 Q2 | 8.88 Million USD | 1.66% |
| 2011 Q3 | 10.37 Million USD | 16.79% |
| 2011 FY | 7.59 Million USD | -30.4% |
| 2010 FY | 10.91 Million USD | 25.6% |
| 2010 Q3 | 10.13 Million USD | 14.27% |
| 2010 Q2 | 8.87 Million USD | 5.96% |
| 2010 Q1 | 8.37 Million USD | -3.68% |
| 2010 Q4 | 10.91 Million USD | 7.69% |
| 2009 Q4 | 8.69 Million USD | -3.04% |
| 2009 FY | 8.69 Million USD | 0.49% |
| 2009 Q2 | 8.06 Million USD | 16.93% |
| 2009 Q1 | 6.89 Million USD | -20.3% |
| 2009 Q3 | 8.96 Million USD | 11.21% |
| 2008 Q1 | 10.09 Million USD | -19.63% |
| 2008 FY | 8.65 Million USD | -31.15% |
| 2008 Q4 | 8.65 Million USD | 3.68% |
| 2008 Q3 | 8.34 Million USD | -19.28% |
| 2008 Q2 | 10.33 Million USD | 2.37% |
| 2007 FY | 12.56 Million USD | 100.59% |
| 2007 Q1 | 5.77 Million USD | -7.82% |
| 2007 Q2 | 5.73 Million USD | -0.73% |
| 2007 Q3 | 7.59 Million USD | 32.41% |
| 2007 Q4 | 12.56 Million USD | 65.55% |
| 2006 FY | 6.26 Million USD | -4.1% |
| 2006 Q4 | 6.26 Million USD | -61.31% |
| 2006 Q3 | 16.19 Million USD | -1.87% |
| 2006 Q1 | 7.6 Million USD | 16.38% |
| 2006 Q2 | 16.49 Million USD | 117.02% |
| 2005 FY | 6.53 Million USD | 14.84% |
| 2005 Q4 | 6.53 Million USD | 0.0% |
| 2004 Q4 | 5.68 Million USD | 0.0% |
| 2004 FY | 5.68 Million USD | 0.0% |
| 2002 FY | 4.69 Million USD | -6.94% |
| 2001 FY | 5.04 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 126.59 Million USD | 61.391% |
| AngioDynamics, Inc. | 112.08 Million USD | 56.392% |
| AtriCure, Inc. | 147.76 Million USD | 66.922% |
| Avinger, Inc. | 19.97 Million USD | -144.733% |
| Azenta, Inc. | 351.22 Million USD | 86.083% |
| BioLife Solutions, Inc. | 75.05 Million USD | 34.874% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 98.81% |
| Daxor Corporation | 858.75 Thousand USD | -5591.708% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | -199.644% |
| Femasys Inc. | 9.4 Million USD | -419.8% |
| GlucoTrack, Inc. | 1.7 Million USD | -2761.71% |
| Harvard Bioscience, Inc. | 64.29 Million USD | 23.975% |
| Hologic, Inc. | 4.02 Billion USD | 98.786% |
| ICU Medical, Inc. | 2.25 Billion USD | 97.832% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 97.609% |
| KORU Medical Systems, Inc. | 8.1 Million USD | -502.896% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -7306.476% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -7306.476% |
| Masimo Corporation | 1.67 Billion USD | 97.085% |
| Microbot Medical Inc. | 3.82 Million USD | -1177.522% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | -94.908% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | 95.648% |
| Nephros, Inc. | 3.5 Million USD | -1295.318% |
| NovoCure Limited | 783.63 Million USD | 93.763% |
| NEXGEL, Inc. | 4.78 Million USD | -920.631% |
| NEXGEL, Inc. | 4.78 Million USD | -920.631% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | 43.468% |
| OraSure Technologies, Inc. | 52.17 Million USD | 6.317% |
| Pro-Dex, Inc. | 23.34 Million USD | -109.39% |
| Pulse Biosciences, Inc. | 16.44 Million USD | -197.239% |
| Predictive Oncology Inc. | 6.14 Million USD | -695.35% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | -614.091% |
| QuidelOrtho Corporation | 3.55 Billion USD | 98.626% |
| Repligen Corporation | 853.2 Million USD | 94.271% |
| Sanara MedTech Inc. | 29.28 Million USD | -66.915% |
| STAAR Surgical Company | 102.73 Million USD | 52.425% |
| Sharps Technology, Inc. | 3.85 Million USD | -1167.918% |
| Utah Medical Products, Inc. | 7.14 Million USD | -584.087% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 98.801% |
| Jin Medical International Ltd. | 8.92 Million USD | -447.693% |